A detailed history of Martingale Asset Management L P transactions in Alkermes Plc. stock. As of the latest transaction made, Martingale Asset Management L P holds 93,273 shares of ALKS stock, worth $2.77 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
93,273
Previous 84,345 10.59%
Holding current value
$2.77 Million
Previous $2.03 Million 28.44%
% of portfolio
0.06%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.01 - $28.55 $205,433 - $254,894
8,928 Added 10.59%
93,273 $2.61 Million
Q2 2024

Aug 12, 2024

SELL
$23.21 - $27.24 $23 - $27
-1 Reduced -0.0%
84,345 $2.03 Million
Q1 2024

May 14, 2024

BUY
$26.4 - $32.56 $26 - $32
1 Added 0.0%
84,346 $2.28 Million
Q4 2023

Feb 12, 2024

SELL
$23.37 - $28.68 $9,418 - $11,558
-403 Reduced 0.48%
84,345 $2.34 Million
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $81 - $95
3 Added 0.0%
84,748 $2.37 Million
Q2 2023

Aug 11, 2023

SELL
$28.34 - $33.63 $113,388 - $134,553
-4,001 Reduced 4.51%
84,745 $2.65 Million
Q4 2022

Feb 13, 2023

BUY
$21.94 - $26.24 $118,168 - $141,328
5,386 Added 6.46%
88,746 $2.32 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $182,930 - $264,999
8,315 Added 11.08%
83,360 $1.86 Million
Q2 2022

Aug 11, 2022

BUY
$26.4 - $30.54 $319,888 - $370,053
12,117 Added 19.26%
75,045 $2.24 Million
Q1 2022

May 12, 2022

BUY
$23.07 - $27.99 $657,887 - $798,190
28,517 Added 82.87%
62,928 $1.66 Million
Q4 2021

Feb 11, 2022

SELL
$21.47 - $32.08 $500,594 - $747,977
-23,316 Reduced 40.39%
34,411 $800,000
Q3 2021

Nov 12, 2021

BUY
$23.37 - $32.13 $1.35 Million - $1.85 Million
57,727 New
57,727 $1.78 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.